Imugene (ASX:IMU) Share Price and News - StockTrack

Market Cap (3-Jul) $107,205,984 (199th)	Close (30-Jun) $0.091 0 (0%)	Volume (30-Jun) 50,159,971	Shortsold (19-Jun) 392,315,164 (5.25%) (41st)
52w High $2.75	52w Low $0.340	P/E -	EPS -0.6

	Subject
	IMU IMU Ann: HER-Vaxx Immunotherapy Patent Granted in Europe
	1 (current) 2 3
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Retirement of Chief Medical Officer
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Release of Securities from Escrow
	IMU IMU Ann: Imugene Receives $6.54 million R&D Tax Incentive
	IMU IMU Ann: South Korea HERVaxx Patent Grant
	IMU IMU Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx
	IMU IMU Ann: Imugene adds industry leaders to senior management team
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Change of Director's Interest Notice - CW
	IMU IMU Ann: Appendix 2A and IMUOB Option Underwriting Agreement
	IMU IMU Ann: Change in substantial holding - PH
	IMU IMU Ann: Imugene HER-Vaxx Immunotherapy Patent Allowed in China
	IMU IMU Ann: Change of Director's Interest Notice - PH
	IMU IMU Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
	IMU IMU Ann: FDA IND APPROVAL FOR ONCOLYTIC VIROTHERAPY VAXINIA
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Change in Joint Company Secretary
	IMU IMU Ann: Update on Clinical Trial of Oncolytic Virotherapy CHECKvacc
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: S&P DJI Announces December 2021 Quarterly Rebalance
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Results of Meeting Percentages
	IMU IMU Ann: Final Director's Interest Notice (AH)
	IMU IMU Ann: Ceasing to be a Director
	IMU IMU Ann: Change of Director's Interest Notice (AH)
	IMU IMU Ann: Results of Meeting
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: AGM Presentation
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Eureka Strategic Collaboration (supplementary announcement)
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Investor Presentation Imugene Eureka Therapeutics
	IMU IMU Ann: Investor webinar Imugene & Eureka Therapeutics Collaboration
	IMU IMU Ann: Imugene and Eureka Therapeutics onCARlytics Collaboration
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Letter to IMUOB Optionholders
	IMU IMU Ann: Change in substantial holding - PH
	IMU IMU Ann: Change of Director's Interest Notice - PH
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMU IMU Ann: Proposed issue of securities - IMU

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
02-Jul	$0.44	1,529,528	+0.42 (3,246.15%)
30-Jun	$0.01	23,981,492	0.00 (0.00%)
27-Jun	$0.01	50,567,876	+0.00 (18.18%)
26-Jun	$0.01	30,696,793	0.00 (8.33%)
24-Jun	$0.01	11,610,882	0.00 (7.69%)
23-Jun	$0.01	14,420,312	0.00 (7.14%)
20-Jun	$0.01	20,575,964	+0.00 (7.69%)
19-Jun	$0.01	23,561,700	0.00 (0.00%)
18-Jun	$0.01	24,687,999	0.00 (13.33%)
16-Jun	$0.02	7,454,486	0.00 (0.00%)
13-Jun	$0.02	8,369,714	0.00 (0.00%)
12-Jun	$0.02	5,001,822	0.00 (6.25%)
06-Jun	$0.02	20,099,905	0.00 (0.00%)
05-Jun	$0.02	30,071,038	0.00 (0.00%)
04-Jun	$0.02	25,081,576	+0.00 (14.29%)
4 up, 5 down, and 6 flat days

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

Imugene Health Care
Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

$0.091 0.002 (2.25%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

$0.091 0.002 (2.25%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care
Cancer Health Care Immunotherapy